PetMed Express, Inc. (PETS) Stock Competitors & Peer Comparison
See (PETS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PETS | $1.83 | -14.08% | 38.1M | -0.65 | -$2.74 | N/A |
| ONC | $282.75 | +2.93% | 29.8B | 62.98 | $4.43 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +2.09% |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| AVLN | $27.40 | +6.55% | 1.1B | -12.94 | -$2.04 | N/A |
| CGEM | $15.33 | -0.07% | 934.8M | -4.51 | -$3.37 | N/A |
| LFMD | $4.75 | +1.28% | 220.5M | -10.36 | -$0.44 | N/A |
| HITI | $2.36 | -1.46% | 203.9M | -5.52 | -$0.42 | N/A |
| LFMDP | $23.60 | -1.38% | 163.7M | -10.64 | -$2.26 | N/A |
Stock Comparison
PETS vs ONC Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, ONC has a market cap of 29.8B. Regarding current trading prices, PETS is priced at $1.83, while ONC trades at $282.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas ONC's P/E ratio is 62.98. In terms of profitability, PETS's ROE is -1.47%, compared to ONC's ROE of +0.12%. Regarding short-term risk, PETS is more volatile compared to ONC. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check ONC's competition here
PETS vs WBA Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, PETS is priced at $1.83, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas WBA's P/E ratio is -1.64. In terms of profitability, PETS's ROE is -1.47%, compared to WBA's ROE of -0.42%. Regarding short-term risk, PETS is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check WBA's competition here
PETS vs HROWL Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, PETS is priced at $1.83, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas HROWL's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, PETS is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check HROWL's competition here
PETS vs HROWM Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, PETS is priced at $1.83, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas HROWM's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, PETS is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check HROWM's competition here
PETS vs AVLN Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, AVLN has a market cap of 1.1B. Regarding current trading prices, PETS is priced at $1.83, while AVLN trades at $27.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas AVLN's P/E ratio is -12.94. In terms of profitability, PETS's ROE is -1.47%, compared to AVLN's ROE of N/A. Regarding short-term risk, PETS is less volatile compared to AVLN. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check AVLN's competition here
PETS vs CGEM Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, CGEM has a market cap of 934.8M. Regarding current trading prices, PETS is priced at $1.83, while CGEM trades at $15.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas CGEM's P/E ratio is -4.51. In terms of profitability, PETS's ROE is -1.47%, compared to CGEM's ROE of -0.51%. Regarding short-term risk, PETS is less volatile compared to CGEM. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check CGEM's competition here
PETS vs LFMD Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, LFMD has a market cap of 220.5M. Regarding current trading prices, PETS is priced at $1.83, while LFMD trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas LFMD's P/E ratio is -10.36. In terms of profitability, PETS's ROE is -1.47%, compared to LFMD's ROE of -1.72%. Regarding short-term risk, PETS is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check LFMD's competition here
PETS vs HITI Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, HITI has a market cap of 203.9M. Regarding current trading prices, PETS is priced at $1.83, while HITI trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas HITI's P/E ratio is -5.52. In terms of profitability, PETS's ROE is -1.47%, compared to HITI's ROE of -0.41%. Regarding short-term risk, PETS is more volatile compared to HITI. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check HITI's competition here
PETS vs LFMDP Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, LFMDP has a market cap of 163.7M. Regarding current trading prices, PETS is priced at $1.83, while LFMDP trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas LFMDP's P/E ratio is -10.64. In terms of profitability, PETS's ROE is -1.47%, compared to LFMDP's ROE of -1.72%. Regarding short-term risk, PETS is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check LFMDP's competition here
PETS vs LFLY Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, LFLY has a market cap of 114.9M. Regarding current trading prices, PETS is priced at $1.83, while LFLY trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas LFLY's P/E ratio is -0.04. In terms of profitability, PETS's ROE is -1.47%, compared to LFLY's ROE of +0.17%. Regarding short-term risk, PETS is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check LFLY's competition here
PETS vs YI Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, YI has a market cap of 45.8M. Regarding current trading prices, PETS is priced at $1.83, while YI trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas YI's P/E ratio is -4.70. In terms of profitability, PETS's ROE is -1.47%, compared to YI's ROE of +0.08%. Regarding short-term risk, PETS is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check YI's competition here
PETS vs RKTO Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, RKTO has a market cap of 40.9M. Regarding current trading prices, PETS is priced at $1.83, while RKTO trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas RKTO's P/E ratio is -2.37. In terms of profitability, PETS's ROE is -1.47%, compared to RKTO's ROE of -1.65%. Regarding short-term risk, PETS is less volatile compared to RKTO. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check RKTO's competition here
PETS vs RAD Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, PETS is priced at $1.83, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas RAD's P/E ratio is -0.05. In terms of profitability, PETS's ROE is -1.47%, compared to RAD's ROE of +2.76%. Regarding short-term risk, PETS is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check RAD's competition here
PETS vs SDEV Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, SDEV has a market cap of 31.2M. Regarding current trading prices, PETS is priced at $1.83, while SDEV trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas SDEV's P/E ratio is -0.20. In terms of profitability, PETS's ROE is -1.47%, compared to SDEV's ROE of +17.15%. Regarding short-term risk, PETS is less volatile compared to SDEV. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check SDEV's competition here
PETS vs RNTX Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, RNTX has a market cap of 28.5M. Regarding current trading prices, PETS is priced at $1.83, while RNTX trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas RNTX's P/E ratio is -0.54. In terms of profitability, PETS's ROE is -1.47%, compared to RNTX's ROE of -2.58%. Regarding short-term risk, PETS is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check RNTX's competition here
PETS vs KYNB Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, KYNB has a market cap of 27.6M. Regarding current trading prices, PETS is priced at $1.83, while KYNB trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas KYNB's P/E ratio is -0.49. In terms of profitability, PETS's ROE is -1.47%, compared to KYNB's ROE of -1.82%. Regarding short-term risk, PETS is more volatile compared to KYNB. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check KYNB's competition here
PETS vs NEUP Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, NEUP has a market cap of 25.4M. Regarding current trading prices, PETS is priced at $1.83, while NEUP trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas NEUP's P/E ratio is -0.59. In terms of profitability, PETS's ROE is -1.47%, compared to NEUP's ROE of -1.10%. Regarding short-term risk, PETS is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check NEUP's competition here
PETS vs MEDS Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, PETS is priced at $1.83, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas MEDS's P/E ratio is -0.31. In terms of profitability, PETS's ROE is -1.47%, compared to MEDS's ROE of -1.21%. Regarding short-term risk, PETS is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check MEDS's competition here
PETS vs POM Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, POM has a market cap of 12.4M. Regarding current trading prices, PETS is priced at $1.83, while POM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas POM's P/E ratio is -0.31. In terms of profitability, PETS's ROE is -1.47%, compared to POM's ROE of +0.07%. Regarding short-term risk, PETS is less volatile compared to POM. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check POM's competition here
PETS vs CJJD Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, PETS is priced at $1.83, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas CJJD's P/E ratio is -0.46. In terms of profitability, PETS's ROE is -1.47%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, PETS is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check CJJD's competition here
PETS vs SSY Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, PETS is priced at $1.83, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas SSY's P/E ratio is -2.86. In terms of profitability, PETS's ROE is -1.47%, compared to SSY's ROE of -0.15%. Regarding short-term risk, PETS is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check SSY's competition here
PETS vs MSLE Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, MSLE has a market cap of 7.7M. Regarding current trading prices, PETS is priced at $1.83, while MSLE trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas MSLE's P/E ratio is -3.36. In terms of profitability, PETS's ROE is -1.47%, compared to MSLE's ROE of -0.67%. Regarding short-term risk, PETS is less volatile compared to MSLE. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check MSLE's competition here
PETS vs AIXC Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, AIXC has a market cap of 6.5M. Regarding current trading prices, PETS is priced at $1.83, while AIXC trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas AIXC's P/E ratio is -0.18. In terms of profitability, PETS's ROE is -1.47%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, PETS is less volatile compared to AIXC. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check AIXC's competition here
PETS vs HKPD Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, HKPD has a market cap of 5.7M. Regarding current trading prices, PETS is priced at $1.83, while HKPD trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas HKPD's P/E ratio is -8.67. In terms of profitability, PETS's ROE is -1.47%, compared to HKPD's ROE of -0.01%. Regarding short-term risk, PETS is more volatile compared to HKPD. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check HKPD's competition here
PETS vs MDVL Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, PETS is priced at $1.83, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas MDVL's P/E ratio is -0.05. In terms of profitability, PETS's ROE is -1.47%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, PETS is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check MDVL's competition here
PETS vs ATNFW Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, PETS is priced at $1.83, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas ATNFW's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, PETS is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check ATNFW's competition here
PETS vs BGMSP Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, PETS is priced at $1.83, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas BGMSP's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, PETS is less volatile compared to BGMSP. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check BGMSP's competition here
PETS vs BGMS Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, BGMS has a market cap of 2.3M. Regarding current trading prices, PETS is priced at $1.83, while BGMS trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas BGMS's P/E ratio is 0.21. In terms of profitability, PETS's ROE is -1.47%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, PETS is more volatile compared to BGMS. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check BGMS's competition here
PETS vs AZNH Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, PETS is priced at $1.83, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas AZNH's P/E ratio is 38.35. In terms of profitability, PETS's ROE is -1.47%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, PETS is more volatile compared to AZNH. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check AZNH's competition here
PETS vs LFLYW Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, PETS is priced at $1.83, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas LFLYW's P/E ratio is -0.04. In terms of profitability, PETS's ROE is -1.47%, compared to LFLYW's ROE of +0.17%. Regarding short-term risk, PETS is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check LFLYW's competition here
PETS vs BIMI Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, BIMI has a market cap of 1.2K. Regarding current trading prices, PETS is priced at $1.83, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas BIMI's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to BIMI's ROE of -2.94%. Regarding short-term risk, PETS is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check BIMI's competition here
PETS vs IPXL Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas IPXL's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, PETS is less volatile compared to IPXL. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check IPXL's competition here
PETS vs OREX Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, OREX has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas OREX's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to OREX's ROE of -0.54%. Regarding short-term risk, PETS is less volatile compared to OREX. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check OREX's competition here
PETS vs CPD Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, CPD has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas CPD's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to CPD's ROE of N/A. Regarding short-term risk, PETS is more volatile compared to CPD. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check CPD's competition here
PETS vs ESRX Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas ESRX's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, PETS is more volatile compared to ESRX. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check ESRX's competition here
PETS vs SHPG Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas SHPG's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, PETS is more volatile compared to SHPG. This indicates potentially higher risk in terms of short-term price fluctuations for PETS.Check SHPG's competition here
PETS vs POZN Comparison June 2026
PETS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETS stands at 38.1M. In comparison, POZN has a market cap of 0. Regarding current trading prices, PETS is priced at $1.83, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETS currently has a P/E ratio of -0.65, whereas POZN's P/E ratio is N/A. In terms of profitability, PETS's ROE is -1.47%, compared to POZN's ROE of +0.61%. Regarding short-term risk, PETS is less volatile compared to POZN. This indicates potentially lower risk in terms of short-term price fluctuations for PETS.Check POZN's competition here